Learn about the Delaware Technology ParkLearn about Delaware Technology Park tenants.Technology communities at the Delaware Technology ParkFlexible space that meets your technological needsDelaware Technology Park newsDelaware Technology Park contact information
     
Delaware Technology Park Ñ Tenant Directory Delaware Technology Park Ñ Closed Resident Discussion Forums Delaware Technology Park Ñ Tenant News and Information

 

Biomune Company
Kristi Moore Dorsey, Ph.D.
VP of Research and Development

Delaware Technology Park
1 Innovation Way, Suite 100, Room 102
Newark, DE 19711

phone: 913-894-0230
fax: 302-368-0236
website: www.biomunecompany.com
e-mail: kmoore@biomunecompany.com

CEVA BIOMUNE is the US based subsidiary of CEVA SANTE ANIMALE one of the world’s fastest growing Animal Health Companies. CEVA BIOMUNE is a US manufacturer of live, inactivated, recombinant and autogenous vaccines for the poultry industry. CEVA BIOMUNE has focused its research and development efforts on technology breakthroughs and new product introductions such as vectored vaccines; first with its line of VECTORMUNE FP poultry vaccines using the fowl poxvirus as a vector; and now with the VECTORMUNE HVT line using the turkey herpesvirus (HVT) as the vector. CEVA Biomune’s VECTORMUNE HVT IBD and VECTORMUNE HVT NDV are the 8th and 9th licenses for vectored poultry vaccines granted to BIOMUNE by the USDA. CEVA Biomune produces a wide range of USDA licensed and customized vaccines for the poultry, cattle and swine industries. For further information call CEVA Biomune at 800-846-0230 or visit the company’s website at www.biomunecompany.com.